We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$320M
AUM Growth
+$8.19M
Cap. Flow
-$1.68M
Cap. Flow %
-0.52%
Top 10 Hldgs %
35.49%
Holding
158
New
13
Increased
22
Reduced
56
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Healthcare 17.23%
3 Consumer Staples 15.6%
4 Financials 14.53%
5 Consumer Discretionary 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
101
Gilead Sciences
GILD
$162B
$463K 0.14%
5,715
CSCO icon
102
Cisco
CSCO
$460B
$449K 0.14%
13,363
-74
-0.6% -$2.36K
KMB icon
103
Kimberly-Clark
KMB
$36.2B
$436K 0.14%
3,703
AES icon
104
AES
AES
$10.5B
$425K 0.13%
38,550
-870
-2% -$9.71K
IJH icon
105
iShares Core S&P Mid-Cap ETF
IJH
$122B
$402K 0.13%
11,225
-2,375
-17% -$82.7K
MA icon
106
Mastercard
MA
$506B
$396K 0.12%
2,805
-600
-18% -$79.4K
POT
107
DELISTED
Potash Corp Of Saskatchewan
POT
$378K 0.12%
19,660
-2,775
-12% -$49.5K
INTU icon
108
Intuit
INTU
$86.4B
$351K 0.11%
2,470
-150
-6% -$20.7K
OPK icon
109
Opko Health
OPK
$993M
$330K 0.1%
48,120
-10,485
-18% -$66.1K
FTS icon
110
Fortis
FTS
$29B
$323K 0.1%
9,024
BABA icon
111
Alibaba
BABA
$293B
$322K 0.1%
+1,865
New +$302K
GS.PRD icon
112
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.02B
$322K 0.1%
13,948
MET icon
113
MetLife
MET
$62B
$319K 0.1%
6,150
-750
-11% -$36.5K
TROW icon
114
T. Rowe Price
TROW
$24.1B
$315K 0.1%
3,480
MO icon
115
Altria Group
MO
$114B
$313K 0.1%
4,931
AGN
116
DELISTED
Allergan plc
AGN
$310K 0.1%
1,513
BNY
117
Bank of New York Mellon
BNY
$107B
$307K 0.1%
5,793
ITW icon
118
Illinois Tool Works
ITW
$82.7B
$300K 0.09%
2,030
TWLO icon
119
Twilio
TWLO
$29.9B
$299K 0.09%
+10,000
New +$300K
AVY icon
120
Avery Dennison
AVY
$13B
$295K 0.09%
3,000
ADP icon
121
Automatic Data Processing
ADP
$106B
$293K 0.09%
2,678
-200
-7% -$21.4K
NKTR icon
122
Nektar Therapeutics
NKTR
$2.39B
$288K 0.09%
+800
New +$250K
BIVV
123
DELISTED
Bioverativ Inc. Common Stock
BIVV
$285K 0.09%
5,000
APA icon
124
APA Corp
APA
$13.2B
$284K 0.09%
6,200
-700
-10% -$30.9K
BLUE
125
DELISTED
bluebird bio
BLUE
$275K 0.09%
154

Similar funds

Fairfield, Bush & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Fairfield, Bush & Co held 158 positions worth $320M, up 2.6% from $312M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fairfield, Bush & Co's Q3 2017 filing shows 13 new, 22 increased, 56 reduced and 8 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 13,405 shares worth $1.74M. The largest sale was Wells Fargo, an estimated $1.74M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Fairfield, Bush & Co's largest Q3 2017 buy was Vanguard Morningstar Total Stock Market ETF: 13,405 shares worth $1.74M.
  • Fairfield, Bush & Co added most to Lockheed Martin in Q3 2017, an estimated $421K increase.
  • Fairfield, Bush & Co's biggest Q3 2017 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Fairfield, Bush & Co fully exited Amplify Snack Brands, Inc. in Q3 2017, selling an estimated $1.05M.
  • Fairfield, Bush & Co's ten largest holdings make up 35% of its $320M portfolio in Q3 2017.
  • Fairfield, Bush & Co opened 13 new positions and closed 8 in Q3 2017.
  • Fairfield, Bush & Co's portfolio value rose 2.6% quarter-over-quarter to $320M.

Based on Fairfield, Bush & Co's 13F filing for Q3 2017, filed 14 Nov 2017.